retatrutide phase 2 trial results vs Phase 3: Wild Results! Retatrutide—A Game Changer in Obesity

PG(14:0)2 for phosphatidylglycerol (PG) and cardiolipin (CL)

10.1016/j.eplepsyres.2019.05.008 63

Participants underwent liver biopsy at the beginning and at the end of the 48-week period

After 68 weeks, half of the participants taking Semaglutide GLP-1 had lost 15 percent of their body weight, and nearly a third had lost 20 percent

GLP-1 receptor agonist drugs like Wegovy, Foundayo and Ozempic are becoming increasingly common, and as more Americans incorporate these medications into their lives, scientists and doctors are learning more about their experienceswhich include side effects

Try to focus solely on your meal to enhance your awareness of what and how much youre consuming